ZAGREB, Aug 10 (Hina) - The Croatian agency for the supervision of financial services HANFA on Thursday stated that the Icelandic company Actavis had submitted a request for the approval of its bid to take over the Croatian
pharmaceutical company Pliva and that HANFA had granted its approval for the US company Barr to publish its bid to take over Pliva.
ZAGREB, Aug 10 (Hina) - The Croatian agency for the supervision of
financial services HANFA on Thursday stated that the Icelandic company Actavis
had submitted a request for the approval of its bid to take over the Croatian
pharmaceutical company Pliva and that HANFA had granted its approval for the US
company Barr to publish its bid to take over Pliva. HANFA said on
its web site that Actavis Group submitted its request for HANFA to approve its
takeover bid through its legal representative, a Zagreb law firm, on August
9.
The deadline for the submission of the request was midnight August
9.
HANFA also said that at its session today it decided to grant its
approval for the US corporation Barr Laboratories Europe B.V. The Netherlands
to publish its takeover bid.
Barr had sent its request to HANFA on July 28.
The price offered by the US company for Pliva is 743 kuna per share,
and the company has also secured bank guarantees from the London office of Bank
of America.